Find Icodextrin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

1RELATED EXCIPIENT COMPANIES

1EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Guanabenz, 5051-62-7, Hydrazinecarboximidamide, 2-[(2,6-dichlorophenyl)methylene]-, (e)-, Dsstox_cid_25666, Dsstox_rid_81042, Dsstox_gsid_45666
Molecular Formula
C8H8Cl2N4
Molecular Weight
231.08  g/mol
InChI Key
WDZVGELJXXEGPV-UHFFFAOYSA-N

Icodextrin
An alpha-2 selective adrenergic agonist used as an antihypertensive agent.
1 2D Structure

Icodextrin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[(2,6-dichlorophenyl)methylideneamino]guanidine
2.1.2 InChI
InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)
2.1.3 InChI Key
WDZVGELJXXEGPV-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 2,6 Dichlorobenzylideneaminoguanidine

2. 2,6-dichlorobenzylideneaminoguanidine

3. Acetate Wyeth-ayerst, Guanabenz

4. Acetate, Guanabenz

5. Br 750

6. Br-750

7. Br750

8. Guanabenz

9. Guanabenz Acetate

10. Guanabenz Acetate Wyeth-ayerst

11. Guanabenz Monoacetate

12. Monoacetate, Guanabenz

13. Wy 8678

14. Wy-8678

15. Wy8678

16. Wyeth Ayerst Of Guanabenz Acetate

17. Wyeth-ayerst Of Guanabenz Acetate

18. Wytensin

2.2.2 Depositor-Supplied Synonyms

1. Guanabenz

2. 5051-62-7

3. Hydrazinecarboximidamide, 2-[(2,6-dichlorophenyl)methylene]-, (e)-

4. Dsstox_cid_25666

5. Dsstox_rid_81042

6. Dsstox_gsid_45666

7. Cas-5051-62-7

8. Ncgc00024846-03

9. Spectrum_000843

10. Prestwick0_000096

11. Prestwick1_000096

12. Spectrum2_001114

13. Spectrum3_000445

14. Spectrum4_000567

15. Kbiogr_000974

16. Kbioss_001323

17. Divk1c_000010

18. Spbio_001248

19. Spbio_001991

20. Chembl1313657

21. Dtxsid6045666

22. Kbio1_000010

23. Kbio2_001323

24. Kbio2_003891

25. Kbio2_006459

26. Kbio3_001310

27. Ninds_000010

28. Hms2233d12

29. Hms3370a17

30. Bcp30851

31. Tox21_110932

32. Akos017264577

33. Tox21_110932_1

34. Zinc242701441

35. Db00629

36. 2,6-dichlorobenzaldehyde Guanylhydrazone

37. Mrf-0000008

38. Ncgc00024846-08

39. Db-051784

40. Ft-0635524

41. Guanabenzum;wy-8678; Wy 8678; Wy8678

42. N-(2,6-dichlorobenzylidene)-n'-amidino Hydrazine

43. Sr-01000721838

44. Sr-01000721838-5

45. Q27164730

2.3 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 231.08 g/mol
Molecular Formula C8H8Cl2N4
XLogP31.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass230.0126017 g/mol
Monoisotopic Mass230.0126017 g/mol
Topological Polar Surface Area76.8 Ų
Heavy Atom Count14
Formal Charge0
Complexity228
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count1
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

For management of High blood pressure


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Guanabenz, a centrally acting α-2 adrenergic agonist, is indicated for treatment of hypertension.


5.2 MeSH Pharmacological Classification

Adrenergic alpha-2 Receptor Agonists

Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)


Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


5.3 Absorption, Distribution and Excretion

Absorption

Approximately 75% absorbed from gastrointestinal tract


5.4 Metabolism/Metabolites

Hepatic


5.5 Biological Half-Life

6 hours.


5.6 Mechanism of Action

Guanabenz's antihypertensive effect is thought to be due to central alpha-adrenergic stimulation, which results in a decreased sympathetic outflow to the heart, kidneys, and peripheral vasculature in addition to a decreased systolic and diastolic blood pressure and a slight slowing of pulse rate. Chronic administration of guanabenz also causes a decrease in peripheral vascular resistance.


API SUPPLIERS

read-more
read-more

01

Baxter Healthcare Corporation

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

STLE Annual Meeting
Not Confirmed
arrow

Baxter Healthcare Corporation

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
STLE Annual Meeting
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

02

Roquette

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

STLE Annual Meeting
Not Confirmed
arrow

Roquette

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
STLE Annual Meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

03

HAINAN YEW PHARMACEUTICAL CO LTD

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

STLE Annual Meeting
Not Confirmed
arrow

HAINAN YEW PHARMACEUTICAL CO LTD

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
STLE Annual Meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

FandaChem

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

STLE Annual Meeting
Not Confirmed
arrow

FandaChem

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
STLE Annual Meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

Shenzhen Haorui

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

STLE Annual Meeting
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 5051-62-7 / Icodextrin API manufacturers, exporters & distributors?

Icodextrin manufacturers, exporters & distributors 1

21

PharmaCompass offers a list of Icodextrin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Icodextrin manufacturer or Icodextrin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Icodextrin manufacturer or Icodextrin supplier.

PharmaCompass also assists you with knowing the Icodextrin API Price utilized in the formulation of products. Icodextrin API Price is not always fixed or binding as the Icodextrin Price is obtained through a variety of data sources. The Icodextrin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Icodextrin

Synonyms

Guanabenz, 5051-62-7, Hydrazinecarboximidamide, 2-[(2,6-dichlorophenyl)methylene]-, (e)-, Dsstox_cid_25666, Dsstox_rid_81042, Dsstox_gsid_45666

Cas Number

5051-62-7

About Icodextrin

An alpha-2 selective adrenergic agonist used as an antihypertensive agent.

Baxter Brand of Icodextrin Manufacturers

A Baxter Brand of Icodextrin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Baxter Brand of Icodextrin, including repackagers and relabelers. The FDA regulates Baxter Brand of Icodextrin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Baxter Brand of Icodextrin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Baxter Brand of Icodextrin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Baxter Brand of Icodextrin Suppliers

A Baxter Brand of Icodextrin supplier is an individual or a company that provides Baxter Brand of Icodextrin active pharmaceutical ingredient (API) or Baxter Brand of Icodextrin finished formulations upon request. The Baxter Brand of Icodextrin suppliers may include Baxter Brand of Icodextrin API manufacturers, exporters, distributors and traders.

click here to find a list of Baxter Brand of Icodextrin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Baxter Brand of Icodextrin USDMF

A Baxter Brand of Icodextrin DMF (Drug Master File) is a document detailing the whole manufacturing process of Baxter Brand of Icodextrin active pharmaceutical ingredient (API) in detail. Different forms of Baxter Brand of Icodextrin DMFs exist exist since differing nations have different regulations, such as Baxter Brand of Icodextrin USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Baxter Brand of Icodextrin DMF submitted to regulatory agencies in the US is known as a USDMF. Baxter Brand of Icodextrin USDMF includes data on Baxter Brand of Icodextrin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Baxter Brand of Icodextrin USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Baxter Brand of Icodextrin suppliers with USDMF on PharmaCompass.

Baxter Brand of Icodextrin KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Baxter Brand of Icodextrin Drug Master File in Korea (Baxter Brand of Icodextrin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Baxter Brand of Icodextrin. The MFDS reviews the Baxter Brand of Icodextrin KDMF as part of the drug registration process and uses the information provided in the Baxter Brand of Icodextrin KDMF to evaluate the safety and efficacy of the drug.

After submitting a Baxter Brand of Icodextrin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Baxter Brand of Icodextrin API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Baxter Brand of Icodextrin suppliers with KDMF on PharmaCompass.

Baxter Brand of Icodextrin NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Baxter Brand of Icodextrin as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Baxter Brand of Icodextrin API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Baxter Brand of Icodextrin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Baxter Brand of Icodextrin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Baxter Brand of Icodextrin NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Baxter Brand of Icodextrin suppliers with NDC on PharmaCompass.

Baxter Brand of Icodextrin GMP

Baxter Brand of Icodextrin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Baxter Brand of Icodextrin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Baxter Brand of Icodextrin GMP manufacturer or Baxter Brand of Icodextrin GMP API supplier for your needs.

Baxter Brand of Icodextrin CoA

A Baxter Brand of Icodextrin CoA (Certificate of Analysis) is a formal document that attests to Baxter Brand of Icodextrin's compliance with Baxter Brand of Icodextrin specifications and serves as a tool for batch-level quality control.

Baxter Brand of Icodextrin CoA mostly includes findings from lab analyses of a specific batch. For each Baxter Brand of Icodextrin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Baxter Brand of Icodextrin may be tested according to a variety of international standards, such as European Pharmacopoeia (Baxter Brand of Icodextrin EP), Baxter Brand of Icodextrin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Baxter Brand of Icodextrin USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty